Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Trimethylamine (TMA) is a short-chain tertiary aliphatic amine that is derived from the diet either directly from the consumption of foods high in TMA or by the intake of food high in precursors to TMA, such as trimethylamine-N-oxide (TMNO), choline and L-carnitine. The clinical significance of TMA may be related to its potential to contribute to neurological toxicity and 'uraemic breath' in patients with end-stage renal disease (ESRD). METHODS: Concentrations of TMA and TMNO in plasma from 10 healthy adults (not on haemodialysis) and 10 adults with ESRD undergoing haemodialysis (pre- and post-dialysis) were determined by gas chromatography-mass spectrometry. RESULTS: The concentrations of TMA and TMNO in pre-dialysis plasma (1.39+/-0.483 and 99.9+/-31.9 microM, respectively) were significantly (P<0.05) higher than the corresponding levels in healthy subjects (0.418+/-0.124 and 37.8+/-20.4 microM, respectively). However, there were no significant differences between post-dialysis and healthy subject plasma concentrations. In the ESRD patients, there was a significant (P<0.05) reduction in plasma TMA (from 1.39+/-0.483 to 0.484+/-0.164 microM) and TMNO (from 99.9+/-31.9 to 41.3+/-18.8 microM) during a single haemodialysis session. CONCLUSIONS: TMA and TMNO accumulate between haemodialysis sessions in ESRD patients, but are efficiently removed during a single haemodialysis session.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TMAO is cleared by the kidney, and prior studies have reported TMAO is elevated in subjects with impaired renal function16–18.”
In the citing paper
“TMAO is cleared by the kidney, and prior studies have reported TMAO is elevated in subjects with impaired renal function16–18.”
In the citing paper
“Differences in characteristics and disease status of participants across studies might affect TMAO levels14, 27, 28 and therefore partly explain such inconsistency.”
From Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta‐Analysis of Prospective Studies (2017) · cites this paper as [28]
In the citing paper
“Serum concentration of TMAO was inversely associated with eGFR and was markedly higher in patients receiving dialysis (59,81); hemodialysis efficiently removed TMAO from blood (8).”
From Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease (2017) · cites this paper as [8]
In the citing paper
“Significantly higher concentrations of TMA and TMAO were noted in plasma from 15 patients with end-stage renal disease compared to 15 healthy counterparts (8).”
From Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease (2017) · cites this paper as [8]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Review on uremic toxins: Classification, concentration, and interindividual variability
Vanholder, R., For the European Uremic Toxin Work Group (EUTox), De Smet, R., Glorieux, G., Argilés, A., Baurmeister, U., Brunet, P., Clark, W., Cohen, G., De Deyn, P. P., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00924.x · Cited by 1,720
Bressolle, F., Bromet-Petit, M., & Audran, M. (1996) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/s0378-4347(96)00088-6 · Cited by 400 · cited 2×
“These results were within reasonable limits for the measurement of endogenous compounds [10].”
BackgroundMethodLang, D., Yeung, C., Peter, R., Ibarra, C., Gasser, R., Itagaki, K., Philpot, R., & Rettie, A. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00218-4 · Cited by 303
Biochemical Profile of Uremic Breath
Simenhoff, M. L., Burke, J. F., Saukkonen, J. J., Ordinario, A. T., Doty, R., & Dunn, S. (1977) · New England Journal of Medicine · doi:10.1056/nejm197707212970303 · Cited by 246 · cited 3×
“TMA and TMNO are of clinical importance because of their possible contribution to neurotoxicity and ‘uraemic breath’ in patients with ESRD [ 7 ].”
BackgroundMethodResultInfluentialDietary Precursors of Trimethylamine in Man: A Pilot Study
Zhang, A. Q., Mitchell, S. C., & Smith, R. L. (1999) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(99)00028-9 · Cited by 232 · cited 2×
“TMA may be derived from the diet either directly by the consumption of foods high in TMA, such as fish, or by the enterobacterial generation of TMA from food rich in trimethylamine-N -oxide (TMNO), choline or L -carnitine [1].”
BackgroundTrimethylaminuria: the fish malodor syndrome.
Mitchell, S. C., & Smith, R. L. (2001) · PubMed · Cited by 209
Approaches to Cancer Prevention Based on an Understanding of N-Nitrosamine Carcinogenesis
Hecht, S. S. (1997) · Experimental Biology and Medicine · doi:10.3181/00379727-216-44168 · Cited by 198 · cited 3×
“N -nitrosodimethylamine does not elicit its carcinogenic effects directly, but requires metabolic activation in the liver, particularly by the cytochrome P450 2E1 isoenzyme, to form highly reactive alkylating intermediates that have the ability to methylate target organ DNA [18].”
BackgroundResultInfluentialThe metabolism of14C-labelled trimethylamine and its N-oxide in man
Al-waiz, M., Mitchell, S. C., Idle, J. R., & Smith, R. L. (1987) · Xenobiotica · doi:10.3109/00498258709043962 · Cited by 143
Mills, G. A., Walker, V., & Mughal, H. (1999) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(98)00542-8 · Cited by 91 · cited 1×
“The plasma samples were analysed for TMA and TMNO using SPME and GC–MS based on the methods described previously [8,9].”
MethodIncreased incidence of neoplasia in chronic renal failure (20-year experience)
Cengiz, K. (2002) · International Urology and Nephrology · doi:10.1023/a:1014489911153 · Cited by 90 · cited 1×
“Other studies have shown higher levels of N -nitrosodimethylamine in the gastrointestinal tract of patients with ESRD compared with healthy controls [16] and, therefore, its potential contribution to an increased incidence of cancer in ESRD patients [17] should be carefully examined.”
Cited by
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Tang, W. H. W., Wang, Z., Kennedy, D. J., Wu, Y., Buffa, J. A., Agatisa-Boyle, B., Li, X. S., Levison, B. S., & Hazen, S. L. (2015) · Circulation Research · doi:10.1161/circresaha.116.305360 · Cited by 1,223
Normal and Pathologic Concentrations of Uremic Toxins
Duranton, F., Cohen, G., De Smet, R., Rodriguez, M., Jankowski, J., Vanholder, R., & Argiles, A. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011121175 · Cited by 961
Heianza, Y., Ma, W., Manson, J. E., Rexrode, K. M., & Qi, L. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004947 · Cited by 544
Wu, G. D., Compher, C., Chen, E. Z., Smith, S. A., Shah, R. D., Bittinger, K., Chehoud, C., Albenberg, L. G., Nessel, L., Gilroy, E., et al. (2016) · Gut · doi:10.1136/gutjnl-2014-308209 · Cited by 512
Trimethylamine N-oxide: the good, the bad and the unknown.
Velasquez, M., Ramezani, A., Manal, A., & Raj, D. (2016) · Toxins · doi:10.3390/toxins8110326 · Cited by 504
Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease
Zeisel, S. H., & Warrier, M. (2017) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071816-064732 · Cited by 475
“Serum concentration of TMAO was inversely associated with eGFR and was markedly higher in patients receiving dialysis (59, 81); hemodialysis efficiently removed TMAO from blood (8).”
BackgroundTrøseid, M., Ueland, T., Hov, J. R., Svardal, A., Gregersen, I., Dahl, C. P., Aakhus, S., Gude, E., Bjørndal, B., Halvorsen, B., et al. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12328 · Cited by 464
Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden
Stubbs, J. R., House, J. A., Ocque, A. J., Zhang, S., Johnson, C., Kimber, C., Schmidt, K., Gupta, A., Wetmore, J. B., Nolin, T. D., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014111063 · Cited by 450
Zoccali, C., Vanholder, R., Massy, Z. A., Ortiz, A., Sarafidis, P., Dekker, F. W., Fliser, D., Fouque, D., Heine, G. H., Jager, K. J., et al. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.52 · Cited by 444
Vaziri, N. D., Zhao, Y.-Y., & Pahl, M. V. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv095 · Cited by 394
“Plasma TMAO level is elevated in CKD and ESRD patients [51, 52].”
BackgroundTrace Amines and Their Receptors
Gainetdinov, R. R., Hoener, M. C., & Berry, M. D. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.015305 · Cited by 384
“Kidney damage (Bain et al., 2006; Chhibber-Goel et al., 2016) and gut dysbiosis (Fennema et al., 2016) can also lead to trimethylaminuria, as can invasion by pathologic microflora associated with bacterial vaginosis or infections of the oral cavity (Fennema et al., 2016; Zhang and Davies, 2016).”
BackgroundLim, Y. J., Sidor, N. A., Tonial, N. C., Che, A., & Urquhart, B. L. (2021) · Toxins · doi:10.3390/toxins13020142 · Cited by 373
“TMAO is efficiently removed by dialytic clearance [87].”
BackgroundA modern approach to the treatment of mitochondrial disease
The Mitochondrial Medicine Society, Parikh, S., Saneto, R., Falk, M. J., Anselm, I., Cohen, B. H., & Haas, R. (2009) · Current Treatment Options in Neurology · doi:10.1007/s11940-009-0046-0 · Cited by 348
Fennema, D., Phillips, I. R., & Shephard, E. A. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.070615 · Cited by 355
“, 1999), impaired renal function (Bain et al., 2006; Hur et al., 2012; Hao et al., 2013) and pancreatic cancer (Navaneethan et al.”
BackgroundThe gut microbiome, diet, and links to cardiometabolic and chronic disorders
Aron-Wisnewsky, J., & Clément, K. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.191 · Cited by 325
Missailidis, C., Hällqvist, J., Qureshi, A. R., Barany, P., Heimbürger, O., Lindholm, B., Stenvinkel, P., & Bergman, P. (2016) · PLOS ONE · doi:10.1371/journal.pone.0141738 · Cited by 338
TMAO: A small molecule of great expectations
Ufnal, M., Zadlo, A., & Ostaszewski, R. (2015) · Nutrition · doi:10.1016/j.nut.2015.05.006 · Cited by 319
Zhang, X., Li, Y., Yang, P., Liu, X., Lu, L., Chen, Y., Zhong, X., Li, Z., Liu, H., Ou, C., et al. (2020) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.313414 · Cited by 291
Qi, J., You, T., Li, J., Pan, T., Xiang, L., Han, Y., & Zhu, L. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13307 · Cited by 268
“TMA is further oxygenated into TMAO by hepatic flavin monooxygenases (FMOs) in host liver, followed by kidney clearance or distribution to different tissues [5].”
BackgroundTrimethylamine N-oxide (TMAO) in human health
Gątarek, P., & Kałużna-Czaplińska, J. (2020) · PubMed · doi:10.17179/excli2020-3239 · Cited by 221
Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis
Nagatomo, Y., & Tang, W. H. W. (2015) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2015.09.017 · Cited by 259
“In humans, TMAO levels were elevated in plasma from patients with CKD [55, 57] and end stage renal failure with hemodialysis [58].”
BackgroundTrimethylamine N-oxide and prognosis in acute heart failure
Suzuki, T., Heaney, L. M., Bhandari, S. S., Jones, D. J. L., & Ng, L. L. (2016) · Heart · doi:10.1136/heartjnl-2015-308826 · Cited by 253
Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins
Lau, W. L., Savoj, J., Nakata, M. B., & Vaziri, N. D. (2018) · Clinical Science · doi:10.1042/cs20171107 · Cited by 237
Lever, M., George, P. M., Slow, S., Bellamy, D., Young, J. M., Ho, M., McEntyre, C. J., Elmslie, J. L., Atkinson, W., Molyneux, S. L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114969 · Cited by 223
“Plasma TMAO has previously been shown to be a marker of renal disease [25, 26], and is a biomarker of fish consumption [38].”
BackgroundTrimethylamine- N -Oxide: Friend, Foe, or Simply Caught in the Cross-Fire?
Cho, C. E., & Caudill, M. A. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.10.005 · Cited by 218
Hoyles, L., Pontifex, M. G., Rodriguez-Ramiro, I., Anis-Alavi, M. A., Jelane, K. S., Snelling, T., Solito, E., Fonseca, S., Carvalho, A. L., Carding, S. R., et al. (2021) · Microbiome · doi:10.1186/s40168-021-01181-z · Cited by 221
Ufnal, M., Jazwiec, R., Dadlez, M., Drapala, A., Sikora, M., & Skrzypecki, J. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.09.010 · Cited by 205
“The concentration of TMAO in blood plasma in mammals has been evaluated in a few studies and was reported to be in the range of 3-40 mmol/L in humans and < 5 mmol/L in mice.(1-3,9) The blood TMAO level depends on several factors, such as the amount of dietary choline, the action of the gut microbiota, and the activity…”
BackgroundJia, J., Dou, P., Gao, M., Kong, X., Li, C., Liu, Z., & Huang, T. (2019) · Diabetes · doi:10.2337/db19-0153 · Cited by 194
“Interestingly, an observational study has reported that TMAO, cleared by the kidney, is elevated in patients with impaired renal function (44) and portends poorer longterm survival (45), suggesting that circulating TMAO might play a role in kidney dysfunction (9,44–46).”
BackgroundHemodialysis‐induced cardiovascular disease
Ahmadmehrabi, S., & Tang, W. H. W. (2018) · Seminars in Dialysis · doi:10.1111/sdi.12694 · Cited by 175
Metabolite Profiling Identifies Markers of Uremia
Rhee, E. P., Souza, A., Farrell, L., Pollak, M. R., Lewis, G. D., Steele, D. J. R., Thadhani, R., Clish, C. B., Greka, A., & Gerszten, R. E. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009111132 · Cited by 184
Kim, R. B., Morse, B. L., Djurdjev, O., Tang, M., Muirhead, N., Barrett, B., Holmes, D. T., Madore, F., Clase, C. M., Rigatto, C., et al. (2016) · Kidney International · doi:10.1016/j.kint.2016.01.014 · Cited by 179
Gut Microbiota and Ischemic Stroke: The Role of Trimethylamine N-Oxide
Nam, H. S. (2019) · Journal of Stroke · doi:10.5853/jos.2019.00472 · Cited by 176
“Dialysis can effectively remove TMAO from the circulation in patients with elevated TMAO levels, and TMAO levels were within normal range after renal transplantation.(31,32) In patients with advanced chronic kidney disease, an elevated TMAO level was found to be independently associated with MACE risk after adjustment…”
BackgroundTrimethylamine N‐oxide: breathe new life
Subramaniam, S., & Fletcher, C. (2018) · British Journal of Pharmacology · doi:10.1111/bph.13959 · Cited by 171
“A prognostic marker in the patients with chronic renal diseases Missailidis et al., 2016; Bain et al., 2006 Human -Progressive renal fibrosis and dysfunction Tang et al., 2015a Human -Ischaemic kidney damage increases circulating TMAO levels Doucet et al., 2004; Hauet et al., 2000a; Hauet et al.,…”
BackgroundMeyer, K. A., Benton, T. Z., Bennett, B. J., Jacobs, D. R., Lloyd‐Jones, D. M., Gross, M. D., Carr, J. J., Gordon‐Larsen, P., & Zeisel, S. H. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003970 · Cited by 172
“TMAO is excreted in urine,(43,44) and circulating TMAO increases as kidney function declines.(45)”
BackgroundPosada-Ayala, M., Zubiri, I., Martin-Lorenzo, M., Sanz-Maroto, A., Molero, D., Gonzalez-Calero, L., Fernandez-Fernandez, B., de la Cuesta, F., Laborde, C. M., Barderas, M. G., et al. (2014) · Kidney International · doi:10.1038/ki.2013.328 · Cited by 167
Kaysen, G. A., Johansen, K. L., Chertow, G. M., Dalrymple, L. S., Kornak, J., Grimes, B., Dwyer, T., Chassy, A. W., & Fiehn, O. (2015) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2015.02.006 · Cited by 164
Metabolomic profiling of uremic solutes in CKD patients
Toyohara, T., Akiyama, Y., Suzuki, T., Takeuchi, Y., Mishima, E., Tanemoto, M., Momose, A., Toki, N., Sato, H., Nakayama, M., et al. (2010) · Hypertension Research · doi:10.1038/hr.2010.113 · Cited by 160
Microbiome, trimethylamine N-oxide, and cardiometabolic disease
Tang, W. H. W., & Hazen, S. L. (2017) · Translational Research · doi:10.1016/j.trsl.2016.07.007 · Cited by 160
Mafra, D., Lobo, J. C., Barros, A. F., Koppe, L., Vaziri, N. D., & Fouque, D. (2014) · Future Microbiology · doi:10.2217/fmb.13.165 · Cited by 157
Trimethylamine N-Oxide in Relation to Cardiometabolic Health—Cause or Effect?
Papandreou, C., Moré, M., & Bellamine, A. (2020) · Nutrients · doi:10.3390/nu12051330 · Cited by 146
“Serum TMAO and TMA levels increased in patients with reduced renal function (haemodialysis patients) [36], showing the importance of renal clearance for TMAO/TMA level regulation.”
BackgroundZhang, Z., Wei, F., Vaziri, N. D., Cheng, X., Bai, X., Lin, R., & Zhao, Y. (2015) · Scientific Reports · doi:10.1038/srep14472 · Cited by 159
“TMA and TMAO accumulate in the body fluids between hemodialysis sessions in patients with ESRD and are efficiently removed by hemodialysis 52 .”
Pelletier, C. C., Croyal, M., Ene, L., Aguesse, A., Billon-Crossouard, S., Krempf, M., Lemoine, S., Guebre-Egziabher, F., Juillard, L., & Soulage, C. O. (2019) · Toxins · doi:10.3390/toxins11110635 · Cited by 152
“showed that the concentrations of TMA and TMAO in pre-dialysis plasma were significantly higher than the corresponding levels in healthy subjects [13].”
BackgroundImpact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression
Castillo-Rodriguez, E., Fernandez-Prado, R., Esteras, R., Perez-Gomez, M. V., Gracia-Iguacel, C., Fernandez-Fernandez, B., Kanbay, M., Tejedor, A., Lazaro, A., Ruiz-Ortega, M., et al. (2018) · Toxins · doi:10.3390/toxins10070300 · Cited by 150
“Haemodialysis efficiently removes TMAO [75].”
Uremic Toxins: An Alarming Danger Concerning the Cardiovascular System
Falconi, C. A., Junho, C. V. C., Fogaça-Ruiz, F., Vernier, I. C. S., da Cunha, R. S., Stinghen, A. E. M., & Carneiro‐Ramos, M. S. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.686249 · Cited by 162
“TMAO has been shown to accumulate in the plasma of CKD patients (Bain et al., 2006), and increased TMAO concentrations are correlated with coronary atherosclerosis (Stubbs et al., 2016).”
BackgroundTMAO is Associated with Mortality: Impact of Modestly Impaired Renal Function
Gruppen, E. G., Garcia, E., Connelly, M. A., Jeyarajah, E. J., Otvos, J. D., Bakker, S. J. L., & Dullaart, R. P. F. (2017) · Scientific Reports · doi:10.1038/s41598-017-13739-9 · Cited by 146
SLCO4C1 Transporter Eliminates Uremic Toxins and Attenuates Hypertension and Renal Inflammation
Toyohara, T., Suzuki, T., Morimoto, R., Akiyama, Y., Souma, T., Shiwaku, H. O., Takeuchi, Y., Mishima, E., Abe, M., Tanemoto, M., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009070696 · Cited by 144
Tian, K., Wang, X., Yu, Z., Li, H., & Guo, X. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b07069 · Cited by 140
Trimethylamine N -oxide: A harmful, protective or diagnostic marker in lifestyle diseases?
Nowiński, A., & Ufnal, M. (2017) · Nutrition · doi:10.1016/j.nut.2017.08.001 · Cited by 138
Xue, R., Dong, L., Zhang, S., Deng, C., Liu, T., Wang, J., & Shen, X. (2008) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.3466 · Cited by 130
Mechanism of Prominent Trimethylamine Oxide (TMAO) Accumulation in Hemodialysis Patients
Hai, X., Landeras, V., Dobre, M. A., DeOreo, P., Meyer, T. W., & Hostetter, T. H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0143731 · Cited by 122
“Plasma levels for TMAO have been reported as elevated in ESRD [11].”
BackgroundThe bright and the dark sides of L-carnitine supplementation: a systematic review
Sawicka, A. K., Renzi, G., & Olek, R. A. (2020) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-020-00377-2 · Cited by 107
Uremic Toxins and Their Relation with Oxidative Stress Induced in Patients with CKD
Pieniążek, A., Bernasinska-Slomczewska, J., & Gwoździński, Ł. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126196 · Cited by 126
Krüger, R., Merz, B., Rist, M. J., Ferrario, P. G., Bub, A., Kulling, S. E., & Watzl, B. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700363 · Cited by 119
“The observed weak association with GFR, and therefore kidney function, is reasonable and in line with literature [31, 32].”
Nanostructured α-MoO3 thin film as a highly selective TMA sensor
Pandeeswari, R., & Jeyaprakash, B. G. (2013) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2013.09.057 · Cited by 115
“Hence TMA serves as the biomarker of renal diseases (Bain et al., 2006).”
BackgroundGrabowska-Polanowska, B., Faber, J., Skowron, M., Miarka, P., Pietrzycka, A., Śliwka, I., & Amann, A. (2013) · Journal of Chromatography A · doi:10.1016/j.chroma.2013.05.012 · Cited by 117
Nutrients Turned into Toxins: Microbiota Modulation of Nutrient Properties in Chronic Kidney Disease
Fernández-Prado, R., Esteras, R., Pérez-Gómez, M. V., Gracia-Iguacel, C., González‐Parra, E., Sanz, A. B., Ortíz, A., & Sánchez-Niño, M. D. (2017) · Nutrients · doi:10.3390/nu9050489 · Cited by 121
“(DMA) and TMAO concentrations are elevated in uremia [92,93], because of decreased GFR with or without derangements in the gut microbiota [22].”
BackgroundBreath ammonia and trimethylamine allow real-time monitoring of haemodialysis efficacy
Endre, Z. H., Pickering, J. W., Storer, M., Hu, W.-P., Moorhead, K. T., Allardyce, R. A., McGregor, D. O. R., & Scotter, J. M. (2010) · Physiological Measurement · doi:10.1088/0967-3334/32/1/008 · Cited by 117
Mafune, A., Iwamoto, T., Tsutsumi, Y., Nakashima, A., Yamamoto, I., Yokoyama, K., Yokoo, T., & Urashima, M. (2016) · Clinical and Experimental Nephrology · doi:10.1007/s10157-015-1207-y · Cited by 103
Microbiota metabolites: Pivotal players of cardiovascular damage in chronic kidney disease
Cosola, C., Rocchetti, M. T., Cupisti, A., & Gesualdo, L. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.03.003 · Cited by 97
“TMAO is normally cleared by the kidneys and, as a result, it is elevated in CKD patients [68]; unlike the other UTs, it has no high affinity with serum albumin, being efficiently removed by the dialytic treatment [69].”
BackgroundZeng, Y., Guo, M., Xia, F., Teng, F., Tan, X., Li, X., Wang, M., Long, Y., & Xu, Y. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab010 · Cited by 103
“In a recent study (77) of the health effects of dietary risks, both the USA and Europe were found to be areas of high red meat consumption.”
BackgroundInfluentialTMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review
Ye, Z., Lulu, C., Xiangchang, Z., Fang, Q., Binjie, Z., Chunyang, L., Rao, T., & Dongsheng, O. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.929262 · Cited by 103
“The levels of TMA and TMAO before hemodialysis in patients with end-stage renal disease (ESRD) are also higher than those in the control (Bain et al., 2006).”
BackgroundThe complex metabolism of trimethylamine in humans: endogenous and exogenous sources
Chhibber-Goel, J., Gaur, A., Singhal, V., Parakh, N., Bhargava, B., & Sharma, A. (2016) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2016.6 · Cited by 93
Davies, S. J., Španěl, P., & Smith, D. C. (2014) · Bioanalysis · doi:10.4155/bio.14.26 · Cited by 90
Identification and Characterization of Trimethylamine-N-oxide Uptake and Efflux Transporters
Teft, W. A., Morse, B. L., Leake, B. F., Wilson, A. S., Mansell, S. E., Hegele, R. A., Ho, R. H., & Kim, R. B. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00937 · Cited by 91
Trimethylamine N-Oxide and Risk of Cardiovascular Disease and Mortality
Kanitsoraphan, C., Rattanawong, P., Charoensri, S., & Senthong, V. (2018) · Current Nutrition Reports · doi:10.1007/s13668-018-0252-z · Cited by 91
Snelson, M., Kellow, N. J., & Coughlan, M. T. (2018) · Advances in Nutrition · doi:10.1093/advances/nmy068 · Cited by 96
Chakraborty, S., & Pal, M. (2019) · Journal of Alloys and Compounds · doi:10.1016/j.jallcom.2019.02.153 · Cited by 88
Gut Microbial Metabolites and Blood Pressure Regulation: Focus on SCFAs and TMAO
Poll, B. G., Cheema, M. U., & Pluznick, J. L. (2020) · Physiology · doi:10.1152/physiol.00004.2020 · Cited by 88
Borges, N. A., Stenvinkel, P., Bergman, P., Qureshi, A. R., Lindholm, B., Moraes, C., Stockler-Pinto, M. B., & Mafra, D. (2019) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-018-9411-1 · Cited by 83
“Thus, further TMAO accumulation may occur in CKD patients, depending on the efficiency of its removal by HD [1, 11].”
Li, Q., Wu, T., Liu, R., Zhang, M., & Wang, R. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700473 · Cited by 85
Molybdenum trioxide nanopaper as a dual gas sensor for detecting trimethylamine and hydrogen sulfide
Li, H., Huang, L., Wang, X., Lee, C.-S., Yoon, J., Zhou, J., Guo, X., & Lee, J. (2017) · RSC Advances · doi:10.1039/c6ra26280e · Cited by 82
Non-volatile compounds in exhaled breath condensate: review of methodological aspects
Rahimpour, E., Khoubnasabjafari, M., Jouyban‐Gharamaleki, V., & Jouyban, A. (2018) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-018-1259-4 · Cited by 80
Diet and Gut Microbiota in Health and Disease
Shen, T. D. (2017) · Nestlé Nutrition Institute Workshop series · doi:10.1159/000455220 · Cited by 82
Ilyas, A., Wijayasinghe, Y. S., Khan, I., Samaloty, N. M. E., Adnan, M., Dar, T. A., Poddar, N. K., Singh, L. R., Sharma, H., & Khan, S. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.964624 · Cited by 76
“The elevated TMAO levels could be reversed by hemodialysis (Bain et al., 2006) or kidney transplantation (Stubbs et al.”
BackgroundFrom taxonomy to metabolic output: what factors define gut microbiome health?
Wilmanski, T., Rappaport, N., Diener, C., Gibbons, S. M., & Price, N. D. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1907270 · Cited by 73
“associated with gut α-diversity have been linked to worse outcomes in chronic kidney disease (CKD) patients (p-cresol sulfate, Trimethylamine N-oxide (TMAO), and phenylacetylglutamine).(66,71) These microbial metabolites can act as cardiac and uremic toxins, particularly in a host whose ability to efficiently filter a…”
BackgroundAwwad, H. M., Geisel, J., & Obeid, R. (2016) · Journal of Chromatography B · doi:10.1016/j.jchromb.2016.10.017 · Cited by 76
Chronic Kidney Disease, Gut Dysbiosis, and Constipation: A Burdensome Triplet
Ikee, R., Sasaki, N., Yasuda, T., & Fukazawa, S. (2020) · Microorganisms · doi:10.3390/microorganisms8121862 · Cited by 75
“The protein-binding affinity of these toxins affects their removal from the circulation by conventional HD: TMAO is efficiently removed [32], whereas IS and PCS are not [33] (Table 1).”
BackgroundChoi, J., Yoon, Y. J., Choi, H.-J., Park, S.-H., Kim, C.-D., Kim, I.-S., Kwon, T., Do, J.-Y., Kim, S.-H., Ryu, D. H., et al. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq554 · Cited by 72
McEntyre, C. J., Lever, M., Chambers, S. T., George, P. M., Slow, S., Elmslie, J. L., Florkowski, C. M., Lunt, H., & Krebs, J. D. (2015) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/0004563214545346 · Cited by 67
“Elevated plasma concentration TMAO has been previously proposed as a maker of renal disease.(27,28) The high intraindividual variability for TMAO concentrations observed in this population may make it difficult to make clinical decisions on the basis of a single measurement.”
BackgroundYamamoto, S., Kazama, J. J., Wakamatsu, T., Takahashi, Y., Kaneko, Y., Goto, S., & Narita, I. (2016) · Renal Replacement Therapy · doi:10.1186/s41100-016-0056-9 · Cited by 77
“weight 75, is increased in hemodialysis patients [7], and clinical research demonstrated an association between serum level of TMAO and cardiovascular disease [8].”
BackgroundStubbs, J. R., Stedman, M. R., Liu, S., Long, J., Franchetti, Y., West, R. E., Prokopienko, A. J., Mahnken, J. D., Chertow, G. M., & Nolin, T. D. (2019) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06190518 · Cited by 69
“01) Age, yr, mean (SD) 54 (14) 53 (15) 53 (15) 54 (14) 53 (13) 56 (13) Women 495 (40%) 104 (42%) 102 (41%) 96 (39%) 102 (41%) 91 (37%) Race Black 256 (21%) 84 (34%) 58 (23%) 42 (17%) 33 (13%) 39 (16%) White 704 (57%) 116 (47%) 126 (77%) 152 (61%) 155 (62%) 155 (63%) Other 283 (23%) 48 (19%) 65 (26%) 55 (22%) 61 (25%)…”
Ocque, A. J., Stubbs, J. R., & Nolin, T. D. (2015) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2015.02.040 · Cited by 68
Yu, H., Geng, W., Zheng, Z., Gao, J., Guo, D., & Wang, Y. (2019) · Theranostics · doi:10.7150/thno.33459 · Cited by 67
“Undertaken to determine TMA reduced from TMAO by the guidance of complex protocols, gas chromatography-mass spectrometry (GC-MS) method suffered from the complicated and laborious procedures, time consumption, and incompleteness of TMAO transformation, limiting its clinical use [9].”
MethodSchneider, C., Okun, J. G., Schwarz, K. V., Hauke, J., Zorn, M., Nürnberg, C., Ungerer, M. N., Ringleb, P. A., & Mundiyanapurath, S. (2020) · European Journal of Neurology · doi:10.1111/ene.14253 · Cited by 67
“Previous clinical studies demonstrated that elevated TMAO levels are found in patients with diabetes [7] and chronic renal failure [8].”
BackgroundGut microbiota dysbiosis in AKI to CKD transition
Rajalakshmi, S. G., & Viswanathan, P. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114447 · Cited by 66
Zhao, X., Zeisel, S. H., & Zhang, S. (2015) · ELECTROPHORESIS · doi:10.1002/elps.201500055 · Cited by 64
Shanmugasundaram, A., Chính, N. Đ., Jeong, Y., Hou, T., Kim, D., Kim, D., Kim, Y.-B., & Lee, D. (2019) · Journal of Materials Chemistry A · doi:10.1039/c9ta00755e · Cited by 64
Dambrova, M., Skapare‐Makarova, E., Konrade, I., Pugovics, O., Grinberga, S., Tirzite, D., Petrovska, R., Kalvins, I., & Liepins, E. (2013) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.135 · Cited by 63
“In addition to the proatherosclerotic effects of TMAO, it has been shown that both TMA and TMAO accumulate in patients with kidney failure.(17) Thus, TMAO‐lowering pharmacological agents might be useful for the maintenance of cardiovascular functionality in patients with high TMAO and L‐carnitine plasma concentrations.”
BackgroundBalancing the Equation: A Natural History of Trimethylamine and Trimethylamine-N-oxide
Loo, R. L., Chan, Q. M., Nicholson, J. K., & Holmes, E. C. (2022) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00851 · Cited by 65
Archaea from the gut microbiota of humans: Could be linked to chronic diseases?
Mafra, D., Ribeiro, M. M., Fonseca, L. D. S., Regis, B., Cardozo, L., dos Santos, H. F., de Jesus, H. E., Schultz, J., Shiels, P. G., Stenvinkel, P., et al. (2022) · Anaerobe · doi:10.1016/j.anaerobe.2022.102629 · Cited by 66
Fiori, J., Turroni, S., Candela, M., Brigidi, P., & Gotti, R. (2018) · Talanta · doi:10.1016/j.talanta.2018.07.051 · Cited by 64
Volatile Organic Compounds in Uremia
Pagonas, N., Vautz, W., Seifert, L., Slodzinski, R., Jankowski, J., Zidek, W., & Westhoff, T. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046258 · Cited by 60
“, trimethylamine is associated with impaired brain function and is suggested to be associated with higher cancer rates in ESRD patients [4,19].”
BackgroundTrimethylamine N-Oxide From Gut Microbiota in Chronic Kidney Disease Patients: Focus on Diet
Moraes, C., Fouque, D. P., Amaral, A. C. F., & Mafra, D. (2015) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2015.06.004 · Cited by 60
Molecular signatures of ovarian diseases: Insights from network medicine perspective
Kori, M., Göv, E., & Arğa, K. Y. (2016) · Systems Biology in Reproductive Medicine · doi:10.1080/19396368.2016.1197982 · Cited by 65
“Trimethylamine is an aliphatic amine, which has a potential to generate a highly toxic carcinogen compound N-nitrosodimethylamine, and cause aberrant neurological symptoms in end-stage renal patients [Bain et al. 2006].”
A Colorimetric Sensor for Qualitative Discrimination and Quantitative Detection of Volatile Amines
Tang, Z., Yang, J., Yu, J., & Cui, B. (2010) · Sensors · doi:10.3390/s100706463 · Cited by 58
“Their existence and concentrations are considered as quality indicators of foods [1,2] and biomarkers in metabolic diseases [3,4].”
BackgroundLi, Y., Lü, H., Guo, J., Zhang, M., Zheng, H., Liu, Y., & Liu, W. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2215542 · Cited by 57
Alzheimer’s disease and gut microbiota: does trimethylamine N-oxide (TMAO) play a role?
Arrona Cardoza, P., Spillane, M. B., & Morales Marroquin, E. (2022) · Nutrition Reviews · doi:10.1093/nutrit/nuab022 · Cited by 53
Mohammadi, A., Najar, A. G., Yaghoobi, M. M., Jahani, Y., & Vahabzadeh, Z. (2016) · Inflammation · doi:10.1007/s10753-015-0261-7 · Cited by 53
“Its levels are elevated in plasma of subjects with end-stage renal disease [12] and in hypertension [13].”
Interplay between gut microbiota, bone health and vascular calcification in chronic kidney disease
Rodrigues, F. G., Ormanji, M. S., Heilberg, I. P., Bakker, S. J. L., & de Borst, M. H. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13588 · Cited by 56
Metadata
- Authors
- Bain, M. A., Faull, R., Fornasini, G., Milne, R. W., & Evans, A. M.
- Affiliations
- University of South Australia (AU)
- Corresponding author
- Bain, Marcus A.
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-01-09
- Volume
- 21
- Issue
- 5
- Pages
- 1300-1304
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2117368544
- Cited by
- 282
- References
- 20
- Citations by year
- 2026: 8 · 2025: 19 · 2024: 13 · 2023: 16 · 2022: 32 · 2021: 22 · 2020: 20 · 2019: 26 · 2018: 17 · 2017: 20 · 2016: 19 · 2015: 21 · 2014: 19 · 2013: 6 · 2012: 6
- FWCI
- 1.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nephrology Dialysis Transplantation (publishedVersion)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Polyamine Metabolism and Applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- trimethylamine, trimethylamine N-oxide, end-stage renal disease, hemodialysis, plasma accumulation, neurotoxicity, choline, L-carnitine, dialysis clearance
- MeSH terms
- Adult, Female, Follow-Up Studies, Renal Dialysis, Humans, Kidney Failure, Chronic, Kidney Function Tests, Male, Methylamines, Middle Aged, Probability, Reference Values, Sensitivity and Specificity, Severity of Illness Index, Biomarkers, Case-Control Studies, Disease Progression, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.